Clonal deletion with bortezomib followed by low or no maintenance immunosuppression in renal allograft recipients.
Trivedi
Hargovind L
HL
Terasaki
Paul I
PI
Feroz
Aziz
A
Vanikar
Aruna V
AV
Trivedi
Varsha B
VB
Khemchandani
Sajni I
SI
Dave
Shruti D
SD
Shankar
Vangipuram
V
Modi
Pranjal R
PR
Kaneku
Hugo
H
Idica
Adam
A
Everly
Matthew J
MJ
D000293:Adolescent; D000328:Adult; D000368:Aged; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D002648:Child; D017637:Clonal Deletion / Q000276:immunology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D007258:Informed Consent; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D011480:Protease Inhibitors / Q000627:therapeutic use*; D011719:Pyrazines / Q000627:therapeutic use*; D014184:Transplantation, Homologous / Q000276:immunology
D001897:Boronic Acids; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib